A newly developed hydrogel, tested on mice, cleaned up traces of glioblastoma tumors and stopped them from returning. The hydrogel was so effective that there was a "striking" 100 percent survival rate in the animals.
Although we can't be sure that the same treatments will achieve that level of success in humans, it's a hugely promising new approach.
Paclitaxel is the chemotherapy drug at the center of the gel, used to make nano-sized filaments for insertion into the brain. The drug is already approved for treating other cancers, including breast and lung cancer.
The hydrogel covers the cancer cavity and the thin grooves left by tumor removal evenly, releasing an antibody called aCD47 over several weeks. It seems the treatment reaches parts of the tumor site that other drugs can miss.
Source: www.sciencealert.com
No comments:
Post a Comment